Back to Newsroom
Back to Newsroom

SHAREHOLDER ALERT: WFC YQ ENOB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Monday, 15 August 2022 01:30 PM

The Law Offices of Vincent Wong

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / August 15, 2022 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Wells Fargo & Company (NYSE:WFC)

If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/wells-fargo-class-action-loss-submission-form?prid=30857&wire=1
Lead Plaintiff Deadline: August 29, 2022
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Wells Fargo common stock between February 24, 2021 and June 9, 2022.

Allegations against WFC include that: (i) Wells Fargo had misrepresented its commitment to diversity in the Company's workplace; (ii) Wells Fargo conducted fake job interviews in order to meet its Diverse Search Requirement; (iii) the foregoing conduct subjected Wells Fargo to an increased risk of regulatory and/or governmental scrutiny and enforcement action, including criminal charges; (iv) all of the foregoing, once revealed, was likely to negatively impact Wells Fargo's reputation; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

17 Education & Technology Group Inc. (NASDAQ:YQ)

If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/17edtech-loss-submission-yq?prid=30857&wire=1
Lead Plaintiff Deadline: September 19, 2022
This lawsuit is on behalf of persons or entities who purchased or otherwise acquired publicly traded 17EdTech securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with 17EdTech's December 2020 initial public offering.

Allegations against YQ include that: (1) 17EdTech's K-12 Academic AST Services would end less than a year after the Company's initial public offering; (2) as part of its ongoing regulatory efforts, Chinese authorities would imminently curtail and/or end 17EdTech's core business; and (3) as a result, defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Enochian BioSciences, Inc. (NASDAQ:ENOB)

If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/enochian-biosciences-inc-loss-submission-form?prid=30857&wire=1
Lead Plaintiff Deadline: September 26, 2022
Class Period: January 17, 2018 - June 27, 2022

Allegations against ENOB include that: (1) the Company's co-founder and inventor Serhat Gumrukcu was engaged in a variety of frauds; (2) Gumrukcu was not a licensed doctor anywhere in the world; (4) as a result of the foregoing, Gumrukcu's purported contributions to the Company lacked a reasonable basis; (5) as a result of the foregoing, the Company had overstated its commercial prospects; (6) Gumrukcu had improperly diverted approximately $20 million from Enochian to entities he owned; and (7) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

The Law Offices of Vincent Wong, Monday, August 15, 2022, Press release picture

To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]

SOURCE: The Law Offices of Vincent Wong

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: